MicroRNA networks surrounding APP and amyloid-β metabolism — Implications for Alzheimer's disease
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
MicroRNAs (miRNAs) are small non-coding RNA regulators of protein synthesis that function as "fine-tuning" tools of gene expression in development and tissue homeostasis. Their profiles are significantly altered in neurodegenerative diseases such as Alzheimer's disease (AD) that is characterized by both amyloid-β (Aβ) and tau deposition in brain. A key challenge remains in determining how changes in miRNA profiles translate into biological function in a physiological and pathological context. The key lies in identifying specific target genes for deregulated miRNAs and understanding which pathogenic factors trigger their deregulation. Here we review the literature about the intricate network of miRNAs surrounding the regulation of the amyloid precursor protein (APP) from which Aβ is derived by proteolytic cleavage. Normal brain function is highly sensitive to any changes in APP metabolism and miRNAs function at several steps to ensure that the correct APP end product is produced and in the right form and abundance. Disruptions in this miRNA regulatory network may therefore alter Aβ production, which in turn can affect miRNA expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992 · cited 2×
“…region at its carboxy-terminus, sAPPβ has been reported to function as a death receptor 6 ligand and to mediate axonal pruning and neuronal cell death (Nikolaev et al., 2009). c99 is subsequently cleaved by the γsecretase complex (that is composed of at least four components; presenilin,…”
RetractedA Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
The impact of microRNAs on protein output
Baek, D., Villén, J., Shin, C., Camargo, F. D., Gygi, S. P., & Bartel, D. P. (2008) · Nature · doi:10.1038/nature07242 · Cited by 3,592 · cited 2×
“One approach to circumvent this inherent problem is to over-express or inhibit individual miRNAs and analyze protein levels by using proteomics approaches such as stable-isotope labeling with amino acid in cell culture (SILAC) (Baek et al., 2008, Selbach et al., 2008).”
Widespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429 · cited 2×
“One approach to circumvent this inherent problem is to over-express or inhibit individual miRNAs and analyze protein levels by using proteomics approaches such as stable-isotope labeling with amino acid in cell culture (SILAC) (Baek et al., 2008, Selbach et al., 2008).”
Regulation of mRNA Translation and Stability by microRNAs
Fabian, M. R., Sonenberg, N., & Filipowicz, W. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060308-103103 · Cited by 3,214 · cited 1×
“Evolutionary conserved, these 19-24 nucleotide-long non-coding RNAs negatively regulate expression of specific mRNA targets through base pairing between their " seed region " and sequences commonly located in the 3'UTR of their targets (Fabian et al., 2010, Siomi and Siomi, 2010).”
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892 · cited 1×
“More specifically, studies in transgenic animals revealed that for Aβ to exert its toxic effects tau is required (Ittner and Gotz, 2011, Ittner et al., 2010, Roberson et al., 2007).”
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821 · cited 1×
“More specifically, studies in transgenic animals revealed that for Aβ to exert its toxic effects tau is required (Ittner and Gotz, 2011, Ittner et al., 2010, Roberson et al., 2007).”
Self-citationAmyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651 · cited 1×
“While increased Aβ levels characterize AD pathology, the precise mechanisms and signaling cascades that Aβ uses to exert its toxicity are only partly understood (da Cruz e Silva et al., 2010, Lim et al., 2010, Palop and Mucke, 2010).”
Faghihi, M. A., Modarresi, F., Khalil, A. M., Wood, D. E., Sahagan, B. G., Morgan, T. E., Finch, C. E., St. Laurent III, G., Kenny, P. J., & Wahlestedt, C. (2008) · Nature Medicine · doi:10.1038/nm1784 · Cited by 1,416 · cited 1×
“Finally, in APP mutant Tg19959 mice, BACE1 levels were increased while miR-103 and -107 levels were decreased (Faghihi et al., 2008), however whether there is a direct relationship or not remains to be elucidated.”
Makeyev, E. V., Zhang, J., Carrasco, M. A., & Maniatis, T. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.015 · Cited by 1,395 · cited 1×
“Given the potentially important role of miR-124 in neuronal maintenance and splicing (Makeyev et al., 2007, Papagiannakopoulos and Kosik, 2009), the authors suggest that loss of this miRNA could be responsible for the above effects possibly through the regulation of its target gene, polypyrimidine…”
MicroRNA-10a binds the 5’UTR of ribosomal protein mRNAs and enhances their translation
Ørom, U. A., Nielsen, F. C., & Lund, A. H. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.001 · Cited by 1,384
A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons
Kim, J., Inoue, K., Ishii, J., Vanti, W. B., Voronov, S. V., Murchison, E., Hannon, G., & Abeliovich, A. (2007) · Science · doi:10.1126/science.1140481 · Cited by 1,187
Hébert, S. S., Horré, K., Nicolaï, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., Kauppinen, S., Delacourte, A., & De Strooper, B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710263105 · Cited by 1,183 · cited 6×
“…or glial cells or both, as both cell types are affected in human 'neurodegenerative' conditions (Kurosinski and Gotz, 2002). miRNA profiling of human cortical tissue identified thirteen 'AD-specific' miRNAs that are down-regulated in human AD brain (Cogswell et al., 2008, Hebert et al., 2008).”
InfluentialAPP processing in Alzheimer’s disease.
Zhang, Y.-W., Thompson, R., Zhang, H., & Xu, H. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-3 · Cited by 983
Increased hippocampal neurogenesis in Alzheimer's disease
Jin, K., Peel, A. L., Mao, X. O., Xie, L., Cottrell, B. A., Henshall, D. C., & Greenberg, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2634794100 · Cited by 971 · cited 2×
“attributed to increased neurogenesis (Jin et al., 2004).”
Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14103 · Cited by 943 · cited 3×
“…relevant to AD. miRNAs -181c, -9, -30c, -148b, -20b and Let7i are particularly interesting as these are also down-regulated in human AD brain (Cogswell et al., 2008, Hebert et al., 2008). miR-9 is the most abundant human brain miRNA (Mattick and Makunin, 2005) and a recurring candidate from…”
Structural Classification of Toxic Amyloid Oligomers
Glabe, C. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800016200 · Cited by 783 · cited 1×
“…of species such as Aβ43 (Saito et al., 2011) or pyroglutamate-modified Aβ42 (Aβ (3(pE)-42) that are believed to be even more toxic than Aβ42 itself, and by the fact that Aβ exists in different aggregation states that includes oligomeric species (Glabe, 2008, Walsh et al., 2002) (Figure 2).”
Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Bertram, L., & Tanzi, R. E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2494 · Cited by 747 · cited 1×
“Here, autosomal dominant mutations have been identified in three genes, in APP itself, as well as in presenilin 1 (PSEN1) and 2 (PSEN2) both of which encode a component of the enzyme complex that is required to generate Aβ (Bertram and Tanzi, 2008).”
Animal models of Alzheimer's disease and frontotemporal dementia
Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676 · cited 3×
“models that express familial mutant forms of the proteins that form the aggregates in human neurodegenerative disease, such as tau or APP (Gotz and Ittner, 2008).”
Self-citationBallard, C., Hanney, M. L., Theodoulou, M., Douglas, S., McShane, R., Kossakowski, K., Gill, R., Juszczak, E., Yu, L.-M., & Jacoby, R. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70295-3 · Cited by 567
Rogers, J. T., Randall, J. D., Cahill, C. M., Eder, P. S., Huang, X., Gunshin, H., Leiter, L., McPhee, J., Sarang, S. S., Utsuki, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207435200 · Cited by 551 · cited 1×
“The APP 5'UTR plays fundamental roles in APP regulation and biogenesis (Lahiri et al., 2005, Maloney et al., 2004, Rogers et al., 2002 ) and although no miRNAs have so far been reported to target the APP 5'UTR, it remains an interesting possibility.”
Cerebellar neurodegeneration in the absence of microRNAs
Schaefer, A., O'Carroll, D., Tan, C. L., Hillman, D., Sugimori, M., Llinas, R., & Greengard, P. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070823 · Cited by 498 · cited 1×
“After nuclear export by Exportin 5/Ran, pre-miRNAs are cleaved in the cytoplasm by Dicer, an enzyme for which neuronal cell-type-specific knock-out mouse strains are available (Cuellar et al., 2008, Davis et al., 2008, Kim et al., 2007, Schaefer et al., 2007), to generate mature miRNAs.”
Alterations of the microRNA network cause neurodegenerative disease
Hébert, S. S., & De Strooper, B. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.12.003 · Cited by 452 · cited 5×
“While these studies suggest a possible transient effect of Aβ plaque pathology on miRNA (miR-106b) expression, miR-106b also regulates APP mRNA levels (Hebert et al., 2009) thus creating a possible regulatory feedback loop.”
InfluentialConditional Loss of Dicer Disrupts Cellular and Tissue Morphogenesis in the Cortex and Hippocampus
Davis, T. H., Cuellar, T. L., Koch, S. M., Barker, A. J., Harfe, B. D., McManus, M. T., & Ullian, E. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4815-07.2008 · Cited by 447 · cited 2×
“After nuclear export by Exportin 5/Ran, pre-miRNAs are cleaved in the cytoplasm by Dicer, an enzyme for which neuronal cell-type-specific knock-out mouse strains are available (Cuellar et al., 2008, Davis et al., 2008, Kim et al., 2007, Schaefer et al., 2007), to generate mature miRNAs.”
Management of agitation and aggression associated with Alzheimer disease
Ballard, C. G., Gauthier, S., Cummings, J. L., Brodaty, H., Grossberg, G. T., Robert, P., & Lyketsos, C. G. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.39 · Cited by 404 · cited 2×
“Finally, anticonvulsants are used off license as an effective treatment of agitation and aggression (Ballard et al., 2009).”
Tomiyama, T., Matsuyama, S., Iso, H., Umeda, T., Takuma, H., Ohnishi, K., Ishibashi, K., Teraoka, R., Sakama, N., Yamashita, T., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5825-09.2010 · Cited by 396 · cited 1×
“While little is known about its physiological role, a plethora of data are available on its aggregation in AD brains where it forms oligomers and fibrils that eventually deposit in the extracellular space as amyloid plaques (Gotz et al., 2011, Ono et al., 2009, Tomiyama et al., 2010).”
Greenfield, J. P., Tsai, J., Gouras, G. K., Hai, B., Thinakaran, G., Checler, F., Sisodia, S. S., Greengard, P., & Xu, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.742 · Cited by 366 · cited 1×
“Full-length APP is synthesized in the endoplasmic reticulum (ER) and then transported through the Golgi apparatus to the trans-Golgi-network (TGN), where in neurons at steady state the highest concentration of APP is found (Greenfield et al., 1999, Hartmann et al., 1997, Xu et al., 1997).”
MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary
Leucht, C., Stigloher, C., Wizenmann, A., Klafke, R., Folchert, A., & Bally-Cuif, L. (2008) · Nature Neuroscience · doi:10.1038/nn.2115 · Cited by 313
Neuroleptic drugs in dementia: benefits and harm
Ballard, C., & Howard, R. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1926 · Cited by 308 · cited 1×
“Patients are further treated with antipsychotic drugs although the benefits are moderate and are accompanied by severe side effects such as sedation and Parkinsonism (Ballard et al., 2009, Ballard and Howard, 2006).”
Wang, X., Liu, P., Zhu, H., Xu, Y., Ma, C., Dai, X., Huang, L., Liu, Y., Zhang, L., & Qin, C. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.08.006 · Cited by 271 · cited 3×
“Some of the deregulated miRNAs in our study became affected prior to Aβ plaque formation (such as miR-409-3p and Let-7i) similar to what is seen in a related study (Wang et al., 2009).”
Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-β
Schonrock, N., Ke, Y. D., Humphreys, D., Staufenbiel, M., Ittner, L. M., Preiss, T., & Götz, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011070 · Cited by 211 · cited 8×
“Although only differing from sAPPα by lacking the Aβ1-16 region at its carboxy-terminus, sAPPβ has been reported to function as a death receptor 6 ligand and to mediate axonal pruning and neuronal cell death (Nikolaev et al., 2009). c99 is subsequently cleaved by the γsecretase complex (that is composed of at least fo…”
InfluentialSelf-citationShibata, M., Kurokawa, D., Nakao, H., Ohmura, T., & Aizawa, S. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3219-08.2008 · Cited by 210
Cited by
Mogilyansky, E., & Rigoutsos, I. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.125 · Cited by 889
“In the AD brain, miR106b was shown to be downregulated in vivo.(97) In relapsing patients with multiple sclerosis (MS), miR-18 was found to be overexpressed compared with controls.”
Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders
Parikshak, N. N., Gandal, M. J., & Geschwind, D. H. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3934 · Cited by 430
“A causal factor, such as genetic variation, that can be used to orient edges to transform an undirected correlational network to a directed causal network. mi RNAs such as miR-339-5p in dementia are in their early stages 155–157 but promise to reveal novel regulators of neurodegeneration.”
BackgroundBurgos, K., Malenica, I., Metpally, R., Courtright, A., Rakela, B., Beach, T., Shill, H., Adler, C., Sabbagh, M., Villa, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094839 · Cited by 385
“Many of the miRNAs we were able to detect as differentially expressed in cell-free CSF and SER have been reported previously in studies examining brain tissue from patients with AD and PD [22,24,26,29,51,52,53,54], or as miRNAs that target genes of particular interest- such as APP, BACE1 and a-synuclein [54,55,56].”
BackgroundMicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer's Disease
Kiko, T., Nakagawa, K., Tsuduki, T., Furukawa, K., Arai, H., & Miyazawa, T. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-130932 · Cited by 256
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease
Denk, J., Boelmans, K., Siegismund, C., Lassner, D., Arlt, S., & Jahn, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126423 · Cited by 236
Metadata
- Authors
- Schonrock, N., Matamales, M., Ittner, L. M., & Götz, J.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 235
- Issue
- 2
- Pages
- 447-454
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2036556087
- Cited by
- 93
- References
- 33
- FWCI
- 4.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.